Vitamin D should be considered as a targeted therapy in glioblastoma cases Cover

.blurhash-client-img { display: none !important; }

Vitamin D should be considered as a targeted therapy in glioblastoma cases

Forum of Clinical Oncology

By: Alexandrina Nikova, Eustathios Vlachakis and Theodossios Birbilis

Open Access

|Mar 2026

Authors

Alexandrina Nikova

nikovaalex@gmail.com

Department of Neurosurgery, Asclipio Voulas Hospital, Athens, Greece

Department of Neurosurgery, Democritus university of Thrace, Alexandroupolis, Greece

Eustathios Vlachakis

Department of neurosurgery, Athens, Greece

Theodossios Birbilis

Department of Neurosurgery, Democritus university of Thrace, Alexandroupolis, Greece

DOI: https://doi.org/10.2478/fco-2024-0017 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X

Journal RSS Feed

Language: English

Published on: Mar 22, 2026

Published by: Helenic Society of Medical Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology

© 2026 Alexandrina Nikova, Eustathios Vlachakis, Theodossios Birbilis, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.